Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Prepaid Assets of $3.3 million for Q1 2026, little changed year-over-year from $3.3 million in Q1 2025, and up 10.63% on a QoQ basis from $3.0 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) has 17 years of Prepaid Assets data on file, last reported at $3.3 million in Q1 2026.
- Quarterly Prepaid Assets changed 0.0% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $3.0 million, down 33.8% from the prior year.
- Prepaid Assets climbed to $3.3 million in Q1 2026 per LXRX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.7 million in Q2 2024 and bottomed at $1.9 million in Q1 2022.
- The 5-year median for Prepaid Assets is $3.7 million (2025), against an average of $4.3 million.
- The widest annual swing landed in 2023, when Prepaid Assets soared 111.46%; it then sank 52.65% in 2025.
- Tracing LXRX's Prepaid Assets over 5 years: stood at $2.5 million in 2022, then surged by 106.77% to $5.1 million in 2023, then fell by 11.66% to $4.5 million in 2024, then slumped by 33.8% to $3.0 million in 2025, then grew by 10.63% to $3.3 million in 2026.
- Per Business Quant, the three latest LXRX Prepaid Assets figures stand at $3.3 million (Q1 2026), $3.0 million (Q4 2025), and $4.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 7.68 Mn |
| Mar 31, 2024 | 7.01 Mn |
| Dec 31, 2023 | 5.13 Mn |
| Sep 30, 2023 | 4.29 Mn |
| Jun 30, 2023 | 6.12 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.82 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Jun 30, 2021 | 4.60 Mn |
| Mar 31, 2021 | 3.95 Mn |
| Dec 31, 2020 | 5.05 Mn |
| Sep 30, 2020 | 9.11 Mn |
| Jun 30, 2020 | 9.46 Mn |
| Mar 31, 2020 | 8.20 Mn |
| Dec 31, 2019 | 5.32 Mn |
| Sep 30, 2019 | 5.97 Mn |
| Jun 30, 2019 | 6.63 Mn |
| Mar 31, 2019 | 4.69 Mn |
| Dec 31, 2018 | 2.67 Mn |
| Sep 30, 2018 | 3.40 Mn |
| Jun 30, 2018 | 3.95 Mn |
| Mar 31, 2018 | 4.28 Mn |
| Dec 31, 2017 | 4.43 Mn |
| Sep 30, 2017 | 4.46 Mn |
| Jun 30, 2017 | 10.17 Mn |
| Mar 31, 2017 | 10.38 Mn |
| Dec 31, 2016 | 3.88 Mn |
| Sep 30, 2016 | 2.44 Mn |
| Jun 30, 2016 | 9.07 Mn |
| Mar 31, 2016 | 14.27 Mn |
| Dec 31, 2015 | 10.14 Mn |
| Sep 30, 2015 | 10.95 Mn |
| Jun 30, 2015 | 7.15 Mn |
| Mar 31, 2015 | 3.19 Mn |
| Dec 31, 2014 | 4.76 Mn |
| Sep 30, 2014 | 5.94 Mn |
| Jun 30, 2014 | 7.34 Mn |
| Mar 31, 2014 | 6.57 Mn |
| Dec 31, 2013 | 4.64 Mn |
| Sep 30, 2013 | 7.26 Mn |
| Jun 30, 2013 | 6.68 Mn |
| Mar 31, 2013 | 8.44 Mn |
| Dec 31, 2012 | 6.35 Mn |
| Sep 30, 2012 | 9.00 Mn |
| Jun 30, 2012 | 6.58 Mn |
| Mar 31, 2012 | 5.14 Mn |
| Dec 31, 2011 | 3.75 Mn |
| Sep 30, 2011 | 4.34 Mn |
| Jun 30, 2011 | 3.87 Mn |
| Dec 31, 2010 | 2.88 Mn |